Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
26,992,583
-
Share change
-
-150,229
-
Total reported value
-
$374,653,368
-
Price per share
-
$13.88
-
Number of holders
-
92
-
Value change
-
-$448,171
-
Number of buys
-
48
-
Number of sells
-
34
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q1 2020
As of 31 Mar 2020,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,992,583 shares.
The largest 10 holders included
Alphabet Inc., Svennilson Peter, BOXER CAPITAL, LLC, BlackRock Inc., Invus Financial Advisors, LLC, VANGUARD GROUP INC, Partner Fund Management, L.P., HILLHOUSE CAPITAL ADVISORS, LTD., STATE STREET CORP, and FRANKLIN RESOURCES INC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.